foxo4-dri peptide senolytic mouse study 2023 Frontiers FOXO4-DRI: Human Trial Status, Cancer
FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research FOXO4 an overview ScienceDirect Topics FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $6.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




